Compare RMCO & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMCO | MYO |
|---|---|---|
| Founded | 2021 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Multi-Sector Companies | Industrial Specialties |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.0M | 36.9M |
| IPO Year | N/A | 2017 |
| Metric | RMCO | MYO |
|---|---|---|
| Price | $2.79 | $0.81 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | 31.3K | ★ 285.1K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | ★ 0.36% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | $209.10 | $9.10 |
| Revenue Next Year | $133.33 | $13.59 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $0.98 | $0.61 |
| 52 Week High | $5.00 | $4.99 |
| Indicator | RMCO | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 43.85 | 55.87 |
| Support Level | $2.80 | $0.80 |
| Resistance Level | $3.82 | $0.85 |
| Average True Range (ATR) | 0.27 | 0.06 |
| MACD | 0.05 | 0.01 |
| Stochastic Oscillator | 54.24 | 52.85 |
Royalty Management Holding Corp formed to invest or purchase assets that have current or near-term income to provide the company with accretive cash flow from which it can reinvest in new assets or expand cash flow from existing assets. These assets typically are natural resources assets (including real estate and mining permits), patents, intellectual property, and emerging technologies.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).